Research
Hormonal
Longer duration of exposure to high sugar availability is associated with higher diabetes prevalence, and reducing sugar availability is associated with subsequent declines in diabetes rates.
Sustained high sugar intake over years increases diabetes risk, and reducing sugar intake can lead to lower diabetes rates over time, even if obesity doesn't change immediately.
ModerateSupportsMEDIUM confidence
Duration and degree of sugar exposure correlated significantly with diabetes prevalence in a dose-dependent manner, while declines in sugar exposure correlated with significant subsequent declines in diabetes rates independently of other socioeconomic, dietary and obesity prevalence changes.
Why this rating
Based on econometric modeling of longitudinal trends, not randomized trials.
Source
The Relationship of Sugar to Population-Level Diabetes Prevalence: An Econometric Analysis of Repeated Cross-Sectional Data
Sanjay Basu et al. · PLoS ONE · 2013
DOI 10.1371/journal.pone.0057873
cross_sectional · n=175Cited 431×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →